Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research

Texto completo
Autor(es):
Ruggiero, Rafael N. ; Rossignoli, Matheus T. ; De Ross, Jana B. ; Hallak, Jaime E. C. ; Leite, Joao P. ; Bueno-Junior, Lezio S.
Número total de Autores: 6
Tipo de documento: Artigo de Revisão
Fonte: FRONTIERS IN PHARMACOLOGY; v. 8, JUN 21 2017.
Citações Web of Science: 7
Resumo

Much of our knowledge of the endocannabinoid system in schizophrenia comes from behavioral measures in rodents, like prepulse inhibition of the acoustic startle and open-field locomotion, which are commonly used along with neurochemical approaches or drug challenge designs. Such methods continue to map fundamental mechanisms of sensorimotor gating, hyperlocomotion, social interaction, and underlying monoaminergic, glutamatergic, and GABAergic disturbances. These strategies will require, however, a greater use of neurophysiological tools to better inform clinical research. In this sense, electrophysiology and viral vector-based circuit dissection, like optogenetics, can further elucidate how exogenous cannabinoids worsen (e.g., tetrahydrocannabinol, THC) or ameliorate (e.g., cannabidiol, CBD) schizophrenia symptoms, like hallucinations, delusions, and cognitive deficits. Also, recent studies point to a complex endocannabinoid-endovanilloid interplay, including the influence of anandamide (endogenous CB1 and TRPV1 agonist) on cognitive variables, such as aversive memory extinction. In fact, growing interest has been devoted to TRPV1 receptors as promising therapeutic targets. Here, these issues are reviewed with an emphasis on the neurophysiological evidence. First, we contextualize imaging and electrographic findings in humans. Then, we present a comprehensive review on rodent electrophysiology. Finally, we discuss how basic research will benefit from further combining psychopharmacological and neurophysiological tools. (AU)

Processo FAPESP: 16/17882-4 - Epilepsias farmacorresistentes: desafios diagnósticos, estudo das comorbidades associadas e novas abordagens experimentais
Beneficiário:João Pereira Leite
Linha de fomento: Auxílio à Pesquisa - Temático
Processo FAPESP: 12/23918-0 - Estudo da plasticidade sináptica da via hipocampo-córtex pré-frontal e suas relações com as alterações comportamentais e moleculares em ratos submetidos a crises febris durante o desenvolvimento
Beneficiário:Rafael Naime Ruggiero
Linha de fomento: Bolsas no Brasil - Doutorado